SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

71,861.40 -777.30
( -1.07%)

Global Indices

Nasdaq

51,194.40 -347.88
(-0.67%)

Dow Jones

7,822.15 -17.78
(-0.23%)

Hang Seng

70,229.08 -454.90
(-0.64%)

Nikkei 225

10,456.95 -84.74
(-0.80%)

Forex

USD-INR

96.37 0.10
(0.10%)

EUR-INR

108.33 0.45
(0.42%)

GBP-INR

127.68 0.44
(0.34%)

JPY-INR

0.61 0.00
(0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Caplin Point Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524742

INE475E01026

269.7614245

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CAPLIPOINT

48.01

20150.32

EPS(TTM)

Face Value()

Div & Yield %

55.22

0.3

Back

Andhra Cements reports standalone net loss of Rs 35.93 crore in the June 2026 quarter

Jul 27,2026

Net Loss of Andhra Cements reported to Rs 35.93 crore in the quarter ended June 2026 as against net loss of Rs 29.62 crore during the previous quarter ended June 2025. Sales rose 42.84% to Rs 142.17 crore in the quarter ended June 2026 as against Rs 99.53 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	142.17	99.53	43
OPM %	2.63	6.67	-
PBDT	-27.01	-12.85	-110
PBT	-47.77	-29.62	-61
NP	-35.93	-29.62	-21

71,861.40 -777.30 ( -1.07%)

51,194.40 -347.88 (-0.67%)

7,822.15 -17.78 (-0.23%)

70,229.08 -454.90 (-0.64%)

10,456.95 -84.74 (-0.80%)

96.37 0.10 (0.10%)

108.33 0.45 (0.42%)

127.68 0.44 (0.34%)

0.61 0.00 (0.01%)